S-15535: Difference between revisions
Appearance
Content deleted Content added
RjwilmsiBot (talk | contribs) m fixing page range dashes using Project:AWB |
No edit summary |
||
Line 7: | Line 7: | ||
| ATC_suffix= |
| ATC_suffix= |
||
| PubChem= 132787 |
| PubChem= 132787 |
||
| DrugBank= |
|||
| C=21 | H=24 | N=2 | O=2 |
| C=21 | H=24 | N=2 | O=2 |
||
| molecular_weight = 336.427 g/mol |
| molecular_weight = 336.427 g/mol |
||
Line 20: | Line 19: | ||
}} |
}} |
||
'''S-15535''' is a [[piperazine]] [[drug]] and research chemical used in scientific studies. It is a [[Potency_(pharmacology)|potent]] and highly selective [[5-HT1A|5-HT<sub>1A</sub>]] [[receptor (biochemistry)|receptor]] [[Ligand_(biochemistry)|ligand]] which acts as an [[agonist]] and [[Antagonist (pharmacology)|antagonist]] (weak [[partial agonist]]) at the presynaptic and postsynaptic 5-HT<sub>1A</sub> receptors, respectively.<ref name="pmid8381359">{{cite journal | author = Millan MJ, Rivet JM, Canton H, Lejeune F, Gobert A, Widdowson P, Bervoets K, Brocco M, Peglion JL. | title = S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist (weak partial agonist) at presynaptic and postsynaptic sites respectively. | journal = Eur J Pharmacol. | volume = 230 | issue = 1 | pages = 99–102 | year = 1993 | pmid = 8381359 }}</ref><ref name="pmid8301575">{{cite journal | author = Millan MJ, Canton H, Gobert A, Lejeune F, Rivet JM, Bervoets K, Brocco M, Widdowson P, Mennini T, Audinot V, et al. | title = Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. | journal = J Pharmacol Exp Ther. | volume = 268 | issue = 1 | pages = 337–352 | year = 1994 | pmid = 8301575 }}</ref><ref name="pmid9223549">{{cite journal | author = Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A. | title = S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. | journal = J Pharmacol Exp Ther. | volume = 282 | issue = 1 | pages = 132–147 | year = 1997 | pmid = 9223549 }}</ref><ref name="pmid9723787">{{cite journal | author = Lejeune F, Millan MJ. | title = Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535. | journal = Synapse. | volume = 30 | issue = 2 | pages = 172–180 | year = 1998 | pmid = 9723787 }}</ref> It has |
'''S-15535''' is a [[piperazine]] [[drug]] and research chemical used in scientific studies. It is a [[Potency_(pharmacology)|potent]] and highly selective [[5-HT1A|5-HT<sub>1A</sub>]] [[receptor (biochemistry)|receptor]] [[Ligand_(biochemistry)|ligand]] which acts as an [[agonist]] and [[Antagonist (pharmacology)|antagonist]] (weak [[partial agonist]]) at the presynaptic and postsynaptic 5-HT<sub>1A</sub> receptors, respectively.<ref name="pmid8381359">{{cite journal | author = Millan MJ, Rivet JM, Canton H, Lejeune F, Gobert A, Widdowson P, Bervoets K, Brocco M, Peglion JL. | title = S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist (weak partial agonist) at presynaptic and postsynaptic sites respectively. | journal = Eur J Pharmacol. | volume = 230 | issue = 1 | pages = 99–102 | year = 1993 | pmid = 8381359 }}</ref><ref name="pmid8301575">{{cite journal | author = Millan MJ, Canton H, Gobert A, Lejeune F, Rivet JM, Bervoets K, Brocco M, Widdowson P, Mennini T, Audinot V, et al. | title = Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. | journal = J Pharmacol Exp Ther. | volume = 268 | issue = 1 | pages = 337–352 | year = 1994 | pmid = 8301575 }}</ref><ref name="pmid9223549">{{cite journal | author = Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A. | title = S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. | journal = J Pharmacol Exp Ther. | volume = 282 | issue = 1 | pages = 132–147 | year = 1997 | pmid = 9223549 }}</ref><ref name="pmid9723787">{{cite journal | author = Lejeune F, Millan MJ. | title = Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535. | journal = Synapse. | volume = 30 | issue = 2 | pages = 172–180 | year = 1998 | pmid = 9723787 }}</ref> It has [[anxiolytic]] properties.<ref name="pmid9723787">{{cite journal | author = Lejeune F, Millan MJ. | title = Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535. | journal = Synapse. | volume = 30 | issue = 2 | pages = 172–180 | year = 1998 | pmid = 9723787 }}</ref><ref name="pmid11041316">{{cite journal | author = Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ. | title = The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents. | journal = Psychopharmacology (Berl). | volume = 152 | issue = 1 | pages = 55–66 | year = 2000 | pmid = 11041316 }}</ref> |
||
⚫ | |||
== References == |
== References == |
||
{{ |
{{Reflist|2}} |
||
{{Anxiolytics}} |
|||
{{Serotonergics}} |
{{Serotonergics}} |
||
{{Piperazines}} |
{{Piperazines}} |
||
Line 32: | Line 31: | ||
[[Category:Piperazines]] |
[[Category:Piperazines]] |
||
[[Category:Indanes]] |
[[Category:Indanes]] |
||
⚫ |
Revision as of 12:47, 16 January 2010
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.150.279 |
Chemical and physical data | |
Formula | C21H24N2O2 |
Molar mass | 336.427 g/mol g·mol−1 |
3D model (JSmol) | |
|
S-15535 is a piperazine drug and research chemical used in scientific studies. It is a potent and highly selective 5-HT1A receptor ligand which acts as an agonist and antagonist (weak partial agonist) at the presynaptic and postsynaptic 5-HT1A receptors, respectively.[1][2][3][4] It has anxiolytic properties.[4][5]
References
- ^ Millan MJ, Rivet JM, Canton H, Lejeune F, Gobert A, Widdowson P, Bervoets K, Brocco M, Peglion JL. (1993). "S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist (weak partial agonist) at presynaptic and postsynaptic sites respectively". Eur J Pharmacol. 230 (1): 99–102. PMID 8381359.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Millan MJ, Canton H, Gobert A, Lejeune F, Rivet JM, Bervoets K, Brocco M, Widdowson P, Mennini T, Audinot V; et al. (1994). "Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists". J Pharmacol Exp Ther. 268 (1): 337–352. PMID 8301575.
{{cite journal}}
: Explicit use of et al. in:|author=
(help)CS1 maint: multiple names: authors list (link) - ^ Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A. (1997). "S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity". J Pharmacol Exp Ther. 282 (1): 132–147. PMID 9223549.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ a b Lejeune F, Millan MJ. (1998). "Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535". Synapse. 30 (2): 172–180. PMID 9723787.
- ^ Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ. (2000). "The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents". Psychopharmacology (Berl). 152 (1): 55–66. PMID 11041316.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)